Express Scripts says likely to lose top client Anthem
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Cantor Fitzgerald Maintains Neutral Rating and $165 PT on Anthem (ANTM); 'Steps to Improve PBM Leverage Should be Positive'
April 24, 2017 5:26 PM EDTCantor Fitzgerald maintains Neutral rating and $165 price target on Anthem (NYSE: ANTM) as the company's pharmacy benefit manager, Express Scripts (ESRX), announced that it is unlikely that Anthem will renew its contract which expires on December 31, 2019.
Analyst Steven Halper notes the company generated... More
